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PANCREATIC ISLET CELL AND
OTHER TUMOURS INDUCED IN
RATS BY HELIOTRINE- A MONO-
ESTER PYRROLIZIDINE ALKALOID;
THE EFFECTS OF ADDITIONAL
TREATMENT WITH NICOTINAMIDE.
R. SCHOENTAL, The Royal Veterinary
College, London.
The carcinogenic action of diester pyr-
rolizidine alkaloids (Schoental, Cancer Res.,
1968, 28, 2237) has been confirmed in several
laboratories (Harris and Chen, Cancer Res.,
1970, 30, 2881; Svoboda and Reddy, ibid.,
1972, 32, 908; Newberne and Rogers, Plant
Foods for Man, 1973, 1, 23).
The mono-ester alkaloid, heliotrine, has
been claimed not to be carcinogenic (Bull,
Culvenor and Dick, The Pyrrolizidine Alka-
loids, 1968, North Holland Publishing Co.).
In experiments to be described, heliotrine
induced in white rats various chronic lesions
and tumours, including adenomata of the
pancreatic islet cells. Pancreatic islet cell
tumours have already been described among
rats treated with pyrrolizidine alkaloids,
including the mono-esters from Amsinckia
intermedia (Schoental, Fowler and Coady,
Cancer Res., 1970, 30, 2127).
TREATMENT OF A METASTASIZING
MURINE TUMOUR WITH CORYNE-
BACTERIUM PARVUM. T. E. SADLER
and J. E. CASTRO, Urology and Transplant
Unit, Royal Postgraduate Medical School,
London.
Effects of Corynebacteriun parvum (C.
parvum) on the metastasizing Lewis lung
carcinoma were studied in C57/B1 mice.
Intravenous or intraperitoneal C. parvum
given at the same time as subcutaneous
inoculation of tumour significantly reduced
the primary tumour mass, and the number
of pulmonary metastases observed at 21
days. Subcutaneous C. parvum had no
effect on either primary tumour or meta-
stases. Macroscopic pulmonary metastases
were not observed 10 days after tumour
inoculation. When the primary tumour
was excised at that time pulmonary meta-
stases were found at 21 days.
Combined effects of surgical excision and
C. parvum on pulmonary metastases were
studied. There was minimal protection when
C. parvUm, and surgery wAere on the same
day but protection occurred when C. parvrum
was given before tumour excision.
In defined conditions surgery and C.
parvum prevent pulmonary metastases from
the Lewis tumour. (This work is supported
by the Cancer Research Campaign.)
MECHANISM OF ACTION OF TU-
MOUR INHIBITORY NITROSO-
UREAS. T. A. CONNORS and J. R. HARE,
Chester Beatty Research Institute, London.
1,3 - Bis(2 - chloroethyl) - 1 - nitrosourea
(BCNU) and related nitrosoureas are highly
selective anti-tumour agents. Because of
their chemical structure, it has been sug-
gested that they act similarly to the bi-
functional alkylating agents. They have
been compared with two alkylating agents
and shown to be quite distinct in a number
of properties: (1) They have a much wider
spectrum of action and can cure animals
with tumours insensitive to alkylating agents;
(2) tumours resistant to BCNU are cross-
resistant to other nitrosoureas but are
collaterally sensitive to alkylating agents;
(3) nitrosoureas rapidly inhibit the incorpora-
tion of precursors into both nucleic acids and
proteins, unlike the alkylating agents which
have a specific effect on thymidine incorpora-
tion into DNA; (4) labelled nitrosoureas
react predominantly with nuclear protein and
only to a small extent with nucleic acids;
(5) BCNU interferes specifically with the
incorporation of thymidine triphosphate into
DNA, and its cytotoxicity can be prevented
by low doses of thymidine.
Although the toxicity of the nitrosoureas
may be due partly to their alkylating
properties, they are quite distinct from the
bifunctional alkylating agents and probably
act by a different mechanism.
DISTRIBUTION STUDIES WITH AN
AMINOPHOSPHONIC ACID ANA-
LOGUE OF DOPA IN MICE BEARING
THE HARDING-PASSEY MELANOMA.
M. J. STRINGER, J. A. STOCK and L. M.
COBB, Chester Beatty Research Institute,
London.
A compound which is incorporated select-
ively into melanin during biosynthesis in
vivo, and which carries an isotope ofadequate
radiotoxicity and short half-life, has a
potential application in the treatment of
iialignanit melanoima. Such therapy -would